drugset / Trial / NCT07231029
A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
An open-label study to evaluate the effect of TS-172 administration on pharmacokinetics in patients with hepatic impairment
Timeline
- Start
- 2025-12-23
- Primary completion
- 2026-10-26
- Completion
- 2026-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TS-172 | Unknown | 20 mg | Oral |
Indications
No indication recorded.